Your browser doesn't support javascript.
loading
Evaluation of factors affecting epidermal growth factor receptor tyrosine kinase inhibitor-induced hepatotoxicity in Japanese patients with non-small cell lung cancer: a two-center retrospective study.
Nagai, Hirofumi; Shimada, Tsutomu; Takahashi, Yoshimitsu; Nishikawa, Mikako; Tozuka, Hiroyuki; Yamamoto, Yasuto; Niwa, Osamu; Takahara, Yutaka; Fujita, Arimi; Nagase, Katsuhiko; Kasahara, Kazuo; Yano, Seiji; Sai, Yoshimichi.
Afiliación
  • Nagai H; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan. n-h59@kanazawa-med.ac.jp.
  • Shimada T; Department of Hospital Pharmacy, University Hospital, Kanazawa Medical University, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa, 920-0293, Japan. n-h59@kanazawa-med.ac.jp.
  • Takahashi Y; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Nishikawa M; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Tozuka H; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Yamamoto Y; Department of Hospital Pharmacy, University Hospital, Kanazawa Medical University, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa, 920-0293, Japan.
  • Niwa O; Department of Hospital Pharmacy, University Hospital, Kanazawa Medical University, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa, 920-0293, Japan.
  • Takahara Y; Department of Hospital Pharmacy, University Hospital, Kanazawa Medical University, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa, 920-0293, Japan.
  • Fujita A; Research Support Center, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa, 920-0293, Japan.
  • Nagase K; Department of Respiratory Medicine, Kanazawa Medical University, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa, 920-0293, Japan.
  • Kasahara K; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Yano S; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Sai Y; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
J Pharm Health Care Sci ; 8(1): 28, 2022 Dec 01.
Article en En | MEDLINE | ID: mdl-36451213
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: J Pharm Health Care Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: J Pharm Health Care Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón